BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 1107579)

  • 1. A comparative study on the genetic effects of hycanthone and oxamniquine.
    Ray VA; Holden HE; Ellis JH; Hyneck ML
    J Toxicol Environ Health; 1975 Nov; 1(2):211-7. PubMed ID: 1107579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of correlation between schistosomicidal and anticholinergic properties of hycanthone and related drugs.
    Pica-Mattoccia L; Cioli D
    J Parasitol; 1986 Aug; 72(4):531-9. PubMed ID: 3783347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic activities of hycanthone and some other antischistosomal drugs.
    Ong TM
    Mutat Res; 1978; 55(1):43-70. PubMed ID: 368622
    [No Abstract]   [Full Text] [Related]  

  • 4. Results of tests for possible transmitted genetic effects of hycanthone in mammals.
    Russell WL
    J Toxicol Environ Health; 1975 Nov; 1(2):301-4. PubMed ID: 1206771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutagenic activities in vitro and in vivo of five antischistosomal compounds.
    Batzinger RP; Bueding E
    J Pharmacol Exp Ther; 1977 Jan; 200(1):1-9. PubMed ID: 319220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of in vitro RNA synthesis by hycanthone, oxamniquine and praziquantel.
    Wong LJ; Tsao GC; Bruce JI; Wong SS
    Experientia; 1990 May; 46(5):461-4. PubMed ID: 1693342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of the mutagenic activity of mazheptil.
    Revazova IuA; Zolotareva GN; Shapiro AA; Abilev SK; Zhurkov VS
    Tsitol Genet; 1975; 9(5):400-3. PubMed ID: 241146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the mode of action of oxamniquine and related schistosomicidal drugs.
    Pica-Mattoccia L; Cioli D
    Am J Trop Med Hyg; 1985 Jan; 34(1):112-8. PubMed ID: 3838223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mutagenic activity of benzonal].
    Fonshteĭn LM; Zolotareva GN; Iskhakova EN; Shapiro AA
    Tsitol Genet; 1976; 10(2):99-102. PubMed ID: 779185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of the mutagenic activity of nitrofurylacrylic acid].
    Zhurkov VS; Shram RIa
    Vopr Pitan; 1981; (4):63-7. PubMed ID: 7027621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term hepatocellular effects of hycanthone and of two other anti-Schistosomal drugs in mice infected with Schistosoma mansoni.
    Haese WH; Bueding E
    J Pharmacol Exp Ther; 1976 Jun; 197(3):703-13. PubMed ID: 180276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Additional statistical evaluation and pharmacological considerations of hycanthone methanesulfonate-induced dominant lethality.
    Green S; Springer JA
    J Toxicol Environ Health; 1975 Nov; 1(2):293-9. PubMed ID: 1206770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of praziquantel in patients with schistosomiasis mansoni previously treated with oxamniquine and/or hycanthone: resistance of Schistosoma mansoni to schistosomicidal agents.
    de Souza Dias LC; de Jesus Pedro R; Deberaldini ER
    Trans R Soc Trop Med Hyg; 1982; 76(5):652-9. PubMed ID: 7179419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NTP Technical Report on the comparative toxicity studies of allyl acetate (CAS No. 591-87-7), allyl alcohol (CAS No. 107-18-6) and acrolein (CAS No. 107-02-8) administered by gavage to F344/N rats and B6C3F1 mice.
    Irwin RD
    Toxic Rep Ser; 2006 Jul; (48):1-73, A1-H10. PubMed ID: 17160105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic toxicology evaluation of the novel semi-synthetic antibiotic piperacillin.
    Cheng M; Manandhar M; Iatropoulos MJ; Noble JF
    Arzneimittelforschung; 1986 Sep; 36(9):1379-83. PubMed ID: 3539126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Observations on the mutagenic power of hycanthone in mammals].
    Léonard A; Léonard ED
    C R Seances Soc Biol Fil; 1976; 170(4):916-8. PubMed ID: 137066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of chromosomes of lymphocytes from patients treated with hycanthone.
    Frota-Pessoa O; Ferreira NR; Pedroso MB; Moro AM; Otto PA; Chamone DA; Da Silva LC
    J Toxicol Environ Health; 1975 Nov; 1(2):305-7. PubMed ID: 1206772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimentally produced resistance of Schistosoma mansoni to hycanthone.
    Jansma WB; Rogers SH; Liu CL; Bueding E
    Am J Trop Med Hyg; 1977 Sep; 26(5 Pt 1):926-36. PubMed ID: 907054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of oxamniquine to the DNA of schistosomes.
    Pica-Mattoccia L; Cioli D; Archer S
    Trans R Soc Trop Med Hyg; 1989; 83(3):373-6. PubMed ID: 2617584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.